H19 and breast carcinoma: Thus, a demonstration of H19 lncRNA function and an identification of H19-CUL4A-ABCB1/MDR1 pathway in chemoresistance have shed new light to the understanding of chemoresistance and will provide new therapeutic targets and strategies for clinical management of breast cancer patients.